Severe spontaneous cases of bisphosphonate-related osteonecrosis of the jaws.
Herbozo
Percival J
PJ
Oral and Maxillofacial Surgery Unit, Hospital de Carabineros, Santiago, Chile.
Briones
Daniel L
DL
Ferres
Alvaro J
AJ
Torrealba
Ramón L
RL
D000368:Aged; D000369:Aged, 80 and over; D000539:Alveolar Process / Q000473:pathology; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D008336:Mandibular Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000601:surgery; D008439:Maxillary Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000601:surgery; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy; D010020:Osteonecrosis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000601:surgery; D011859:Radiography; D012720:Severity of Illness Index; D000077211:Zoledronic Acid
D000970:Antineoplastic Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid